EUVIMED · CrossrefZeitschrift
Regulatory Research and Medicine Evaluation
ISSN 3034-3062 · SCEEMP
Neueste Artikel
Expert Scientific Panels of the Scientific Centre for Expert Evaluation of Medicinal Products as an Instrument for Regulatory Foresight and Harmonization of EAEU Requirements (Interview)
Targeted Radionuclide Therapy and Diagnostics of EGFR-Expressing Tumors: Current State and Future Perspectives (Review)
Compliance with Good Manufacturing Practice Requirements in the Manufacture of Advanced Therapy Medicinal Products in Public Healthcare Institutions: A Review of Implementation Barriers
Validation of a High-Performance Liquid Chromatography Method for Histamine Determination in Enoxaparin Sodium Medicinal Products
Uncertainty of the Results of Microbiological Analysis of Medicinal Products: An Example of Assessment under Conditions of Within-Laboratory Precision
Escherichia coli Strain ATCC 25922 as a Promising Test Microorganism for Determining the Antimicrobial Activity of a Number of Antibiotics
Quantitative Determination of Total Flavonoids in Onosma simplicissima Herb: Method Development and Validation
On the Question of Sample Size Planning in Bioequivalence Studies from the Perspective of Desired Statistical Power
Development of the Technology for Producing Capsules with a Compound Extract of Oplopanax elatus, Sophora japonica, and Origanum vulgare Using a Risk-Based Approach
Pyrrolizidine Alkaloids of Boraginaceae Family and Safety Assessment of Acute Toxicity
Identifying Histamine Impurity in Biological Products: Prospective Transition from in vivo to in vitro Methods
Regulatory Requirements for Small-Scale Preparation of Radiopharmaceuticals
New Species of Herbal Medicines in the Russian Pharmacopoeia: Nomenclature and Quality Requirements (Review)
Analysis of Current Approaches to Monitoring the Content of Depressor Substances
Calendula Flowers (Calendulae officinalis flos): Methods to Obtain Fractions of Biologically Active Substances
Current Approaches to Planning and Conducting Clinical Trials of Medicinal Products for the Treatment of Crohn's Disease
Effect of Sample Preparation and Chromatographic Conditions on Background Signal
Determination of Anthracene Derivatives in the Antihaemorrhoidal Medicinal Herb Mixture Proctophytol® Using the European Pharmacopoeia Method
Methodological Approaches to Determination of Depressor Substances in Medicinal Products
Current Approaches to the Abnormal Toxicity Test
Therapeutic Drug Monitoring, CYP2C9 Genotyping and Phenotyping in the Treatment of Diabetes with Glibenclamide Products
Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies
Preclinical Studies in the Pharmaceutical Development Cycle
Non-clinical Studies of Radiopharmaceuticals: Analysis of National and International Regulatory Practice (Review)
Practical Aspects of Assessing Toxic Lesions of the Peripheral Nervous System in Preclinical Studies in Rodents: A Review
Complex Assessment of the Functional State of the Urinary System in Preclinical Studies. Part 1. Instrumental and Laboratory Assessment Methods (Review)
Optimisation of a Cytogenetic Sample Preparation Procedure for In Vivo Metaphase Analysis of Mammalian Bone Marrow Cells
Pharmacokinetics Study of a New Isoxazole Derivative in Rats Using HPLC-MS/MS for Blood Sample Analysis
Validation of an Analytical Procedure for Evaluating the Biological Activity of a Medicinal Product Based on Tocilizumab and Determination of Acceptance Criteria for Test Results
Determination of Biological Activity of Gonadotrophins in Randombred and Sprague Dawley Rats. Part 2. Determination of Biological Activity of Luteinising Hormone
EUVIMED